Abstract: An artificial intelligence (AI) agent interacts with patients via a user interface presented on a computing device. The AI agent may be trained by generating, based on session logs of a cohort of subjects interacting with the user interface, one or more training datasets comprising data on user interactions with the user interface by subjects in the cohort, and data based on health records of the subjects in the cohort of subjects. Machine-learning techniques may be applied to the training datasets to train the AI agent. Based on interactions of a patient with the AI agent, the AI agent may generate a recommendation for a medical screening, a medical procedure, etc. The recommendation may additionally be based on data in an electronic health record of the patient. Data on interactions with additional patients may be used to update models employed through the AI agent.

Abstract: An artificial intelligence (AI) agent interacts with patients via a user interface presented on a computing device. The AI agent may be trained by generating, based on session logs of a cohort of subjects interacting with the user interface, one or more training datasets comprising data on user interactions with the user interface by subjects in the cohort, and data based on health records of the subjects in the cohort of subjects. Machine-learning techniques may be applied to the training datasets to train the AI agent. Based on interactions of a patient with the AI agent, the AI agent may generate a recommendation for a medical screening, a medical procedure, etc. The recommendation may additionally be based on data in an electronic health record of the patient. Data on interactions with additional patients may be used to update models employed through the AI agent.

Abstract: The present invention relates to an environmental sampling method for assessing airborne microorganisms. The method comprises retaining organisms suspended in air to a polymeric pad via gravitational settling or forced impact, dissolving the polymeric pad in a buffered salt solution, and determining the number and kind of microorganisms in the buffered salt solution. Neither the polymeric pad nor the buffered salt solution inhibits the growth of the microorganisms to be determined.

Abstract: The present invention relates to a method for culturing Brevundimonas diminuta for filtration validation. The method comprises inoculating the B. diminuta cells in an appropriate medium, growing the inoculated medium in a gas-impermeable chamber, wherein there is room for air in the headspace of the chamber, wherein air is continually passed through the headspace, and rocking the chamber to induce wave in the medium.